Mark J Tarr, Director, President & CEO, on August 10, 2026, sold 173,148 shares in Encompass Health (EHC) for $21,724,095. Following the Form 4 filing with the SEC, Tarr has control over a total of 267,814 common shares of the company, with 267,814 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/785161/000078516126000191/xslF345X05/wk-form4_1786474034.xml
Price: $125.17, Change: $-0.64, Percent Change: -0.51%